The Predictive Value of Potential Hematological Biomarkers in Acute Coronary Syndrome

Clinical Laboratory
|October 19, 2019
PubMed

Insights

Neutrophil-to-lymphocyte ratio (NLR) effectively predicts acute coronary syndrome (ACS) outcomes and 30-day mortality. Combining NLR with platelet-to-lymphocyte ratio (PLR), monocyte percentage (MO), and white blood cell count (WBC) enhances its predictive power for ACS.

Area of Science:

  • Cardiology
  • Hematology
  • Biomarker Discovery

Background:

  • Acute coronary syndrome (ACS) requires reliable predictive markers.
  • Hematological parameters are increasingly recognized for their prognostic value.

Purpose of the Study:

  • To evaluate the predictive capability of hematological biomarkers for ACS outcomes.
  • To assess the association of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), white blood cell count (WBC), and monocyte percentage (MO) with ACS prognosis.

Main Methods:

  • Retrospective analysis of 309 ACS patients (UA, STEMI, NSTEMI).
  • Investigated associations between NLR, PLR, WBC, MO, and platelet width (PLW) with cardiac troponin I (cTnI), coronary artery occlusion, emergent PCI, and 30-day mortality.
  • Utilized t-tests, chi-square tests, non-parametric tests, and multivariate logistic regression.

Main Results:

  • NLR, PLR, MO, and WBC showed significant associations with emergent PCI and 30-day mortality (p < 0.05), except for PLW.
  • NLR emerged as the strongest predictor of 30-day mortality.
  • Significant associations were found between NLR, PLR, WBC, and cTnI levels (p < 0.05).

Conclusions:

  • NLR is a valuable and accessible biomarker for predicting ACS outcomes.
  • Combining NLR with PLR, MO, and WBC improves its predictive significance in ACS.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
741
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
505
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
186
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
321
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
232
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
683